Azerbaijan vs Lesotho: Access to anti-retroviral drugs, female
Azerbaijan
98.0%
in 2024
Lesotho
98.0%
in 2024
Azerbaijan rank
1st
Lesotho rank
1st
Access to anti-retroviral drugs, female over time
- Azerbaijan
- Lesotho
How they compare
Azerbaijan currently reports 98.0% against 98.0% in Lesotho, a difference of 0.0%.
Across all 24 years both countries report, Lesotho has been ahead every year.
Azerbaijan ranks 1st and Lesotho ranks 1st of 141 countries.
Lesotho has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.0% | 8.2% | 7.2% | Lesotho |
| 2010s | 32.0% | 55.4% | 23.4% | Lesotho |
| 2020s | 83.6% | 91.4% | 7.8% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Azerbaijan or Lesotho?
- Azerbaijan, at 98.0% against 98.0% in Lesotho as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Azerbaijan and Lesotho?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Lesotho?
- 24 years are reported by both, from 2000 to 2024.
- How do Azerbaijan and Lesotho rank globally for access to anti-retroviral drugs, female?
- Azerbaijan ranks 1st and Lesotho ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.